Literature DB >> 17901650

Cutaneous leishmaniasis: an emerging infection in a non-endemic area and a brief update.

V Rastogi1, P S Nirwan.   

Abstract

We report here the emergence of a new focus of cutaneous leishmaniasis (CL) due to Leishmania tropica (L. tropica) in the Ajmer city of Rajasthan, India, a previously non-endemic area. Between January-February 2006, 13 new indigenously acquired cases of CL were diagnosed among the patients attending the Skin and STD department, JLN Hospital, Ajmer. The diagnosis was based on clinical presentation, demonstration of amastigotes (LT bodies) in Giemsa stained smear of the lesion and response to intralesional / local anti-leishmanial drug therapy. In addition, culture of the promastigote forms of L. tropica from the lesion was successfully attempted in four of the smear negatives cases. By retrospective analysis, 23 new indigenous cases of CL have been diagnosed in the same setting during the period January 2004 - December 2005, based on clinical and therapeutic response alone. There was no clear-cut history of sandfly bite and travel outside the district or state to endemic area in any of the cases. However, all of them came from a common residential area (famous dargah of Ajmer) and the peak incidence was seen in January, four months after the famous Urs fair of Ajmer, the location was urban and the lesions were characteristic of L. tropica. Therefore, the disease is suspected to be anthroponotic. These features are suggestive of a common mode of transmission, source and/or vector signalling introduction of this infection into a non-endemic area.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901650     DOI: 10.4103/0255-0857.34774

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  9 in total

Review 1.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  Unusual presentation of cutaneous leishmaniasis.

Authors:  P S Sindhu; V Ramesh
Journal:  Indian J Dermatol       Date:  2012-01       Impact factor: 1.494

3.  Trend of cutaneous leishmaniasis in kermanshah province, west of iran from 1990 to 2012.

Authors:  Yazdan Hamzavi; Nahid Khademi
Journal:  Iran J Parasitol       Date:  2015 Jan-Mar       Impact factor: 1.012

4.  First reported cases of diffuse cutaneous leishmaniasis in human immunodeficiency virus positive patients in Jaipur District of Rajasthan, India.

Authors:  Saroj Hooja; Babita Sharma; Arpita Jindal; Nitya Vyas
Journal:  Trop Parasitol       Date:  2014-01

5.  Clinical study of cutaneous leishmaniasis in the Kashmir Valley.

Authors:  Mahmood Dhahir Al-Mendalawi
Journal:  Indian Dermatol Online J       Date:  2016 Nov-Dec

6.  Cutaneous leishmaniasis in Bikaner, India: Clinicoepidemiological profile; parasite identification using conventional, molecular methods and CL Detect™ rapid test, a new Food and Drug Administration-approved test.

Authors:  Ekadashi Rajni; B C Ghiya; Sarman Singh; Prem Shankar; Taruna Swami; Deepika Singh Jadon; S R Negi; Manisha Malik; P K Khatri
Journal:  Trop Parasitol       Date:  2019-09-18

7.  A Clinico-Epidemiological Study of Cutaneous Leishmaniasis in a Non-Endemic Region of South Rajasthan.

Authors:  Rekha Virath; Lalit K Gupta; Sharad Mehta; Manisha Balai; Asit K Mittal; Ashok K Khare
Journal:  Indian Dermatol Online J       Date:  2020-09-28

8.  Cutaneous Leishmaniasis in a Nonendemic Area of South Rajasthan: A Prospective Study.

Authors:  Manisha Balai; Lalit Kumar Gupta; Ashok Kumar Khare; Ankita Srivastava; Asit Mittal; Ajit Singh
Journal:  Indian J Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.494

9.  Lupoid cutaneous Leishmaniasis: A Report of Three Cases from Nonendemic Area.

Authors:  Lalit Kumar Gupta; Soniya Meena; Ashok Kumar Khare; Manisha Balai; Asit Mittal; Sharad Mehta
Journal:  Indian J Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.